Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2023 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2023 Earnings Call Transcript August 8, 2023

Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $0.34.

Operator: Good evening, ladies and gentlemen, and welcome to Anika’s Second Quarter 2023 Earnings Conference Call. [Operator Instructions]. I will now turn the call over to Mark Namaroff, Vice President, Investor Relations, ESG and Corporate Communications. Please go ahead.

Mark Namaroff: Thank...